Zevra Therapeutics, Inc. ZVRA Total debt

Total debt at other companies

BioMarin PharmaceuticalsBMRN

$4.19B+598%

RFL

Rafael Holdings, Inc.RFL

$21.9M+995%

Rigel PharmaceuticalsRIGL

$68.36M+5,079%

XER

Xeris Biopharma Holdings, Inc.XERS

$289.44M+12.5%

Theravance BiopharmaTBPH

$40.5M-15.9%

Eton Pharmaceuticals, Inc.ETON

$31.26M+3.7%

FAQ

What is Zevra Therapeutics, Inc.'s total debt?

Zevra Therapeutics, Inc. (ZVRA) reported total debt of $1.5M in Q2 2026.

How has Zevra Therapeutics, Inc.'s total debt changed year-over-year?

Zevra Therapeutics, Inc.'s total debt decreased by 97.6% year-over-year, from $62.28M to $1.5M.

What is the long-term trend for Zevra Therapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total debt has grown at a 97.4% compound annual growth rate (CAGR), from $2.11M to $63.21M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.